Effectiveness and Community Acceptance of Extending Seasonal Malaria Chemoprevention to Children 5 to 14 Years of Age in Dangassa, Mali
- PMID: 34781256
- PMCID: PMC8832934
- DOI: 10.4269/ajtmh.21-0046
Effectiveness and Community Acceptance of Extending Seasonal Malaria Chemoprevention to Children 5 to 14 Years of Age in Dangassa, Mali
Abstract
Seasonal malaria chemoprevention (SMC) was adopted in Mali in 2012 for preventing malaria in children younger than 5 years. Although this strategy has been highly effective in reducing childhood malaria, an uptick in malaria occurrence has occurred in children 5 to 15 years of age. This study aimed to investigate the feasibility of providing SMC to older children. A cohort of 350 children age 5 to 14 years were monitored during the 2019 transmission season in Dangassa, Mali. The intervention group received five monthly rounds of sulfadoxine-pyrimethamine plus amodiaquine, whereas the control group consisted of untreated children. Community acceptance for extending SMC was assessed during the final round. Logistic regression models were applied to compare the risk of Plasmodium falciparum malaria infection, anemia, and fever between the intervention and control groups. Kaplan-Meier survival analyses were used to compare the time to P. falciparum parasitemia infection between the groups. The community acceptance rate was 96.5% (139 of 144). Significant declines were observed in the prevalence of P. falciparum parasitemia (adjusted odds ratio, 0.22; 95% CI, 0.11-0.42) and anemia (adjusted odds ratio, 0.15; 95% CI, 0.07-0.28) in the intervention group compared with the control group. The cumulative incidence of P. falciparum infections was significantly greater (75.4%, 104 of 138) in the control group compared with the intervention group (40.7%, 61 of 143, P = 0.001). This study reveals that expanding SMC to older children is likely feasible, has high community acceptance, and is in reducing uncomplicated malaria and anemia in older children.
Trial registration: ClinicalTrials.gov NCT04149106.
Figures




Similar articles
-
High incidence of clinical malaria among asymptomatic Plasmodium falciparum infected children receiving SMC with sulfadoxine-pyrimethamine and amodiaquine (SP + AQ) in Koulikoro, Mali.Malar J. 2025 Mar 27;24(1):102. doi: 10.1186/s12936-025-05283-z. Malar J. 2025. PMID: 40140803 Free PMC article.
-
Relationship between red blood cell polymorphisms and effectiveness of seasonal malaria chemoprevention in 2020 in Dangassa, Mali.Parasitol Res. 2024 Oct 14;123(10):350. doi: 10.1007/s00436-024-08372-1. Parasitol Res. 2024. PMID: 39400721 Clinical Trial.
-
Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.Malar J. 2017 Aug 10;16(1):325. doi: 10.1186/s12936-017-1974-x. Malar J. 2017. PMID: 28797263 Free PMC article.
-
Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention.Am J Trop Med Hyg. 2023 Dec 11;110(1):20-31. doi: 10.4269/ajtmh.23-0481. Print 2024 Jan 3. Am J Trop Med Hyg. 2023. PMID: 38081050 Free PMC article.
-
Effect of seasonal malaria chemoprevention in children between 5 and 9 years old in Kita and Bafoulabe districts, Mali.Parasite Epidemiol Control. 2022 Jun 22;18:e00258. doi: 10.1016/j.parepi.2022.e00258. eCollection 2022 Aug. Parasite Epidemiol Control. 2022. PMID: 35789762 Free PMC article. Review.
Cited by
-
Household-level effects of seasonal malaria chemoprevention in the Gambia.Commun Med (Lond). 2024 May 22;4(1):97. doi: 10.1038/s43856-024-00503-0. Commun Med (Lond). 2024. PMID: 38778226 Free PMC article.
-
International Centers of Excellence for Malaria Research: Achievements of the Collaborative Network during the Past Decade.Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):1-4. doi: 10.4269/ajtmh.22-0209. Print 2022 Oct 11. Am J Trop Med Hyg. 2022. PMID: 36228912 Free PMC article. No abstract available.
-
Population impact of malaria control interventions in the health district of Kati, Mali.PLoS One. 2024 Dec 31;19(12):e0289451. doi: 10.1371/journal.pone.0289451. eCollection 2024. PLoS One. 2024. PMID: 39739743 Free PMC article.
-
Modeling clinical malaria episodes in different ecological settings in Mali, 2018-2022.IJID Reg. 2023 Nov 11;10:24-30. doi: 10.1016/j.ijregi.2023.11.006. eCollection 2024 Mar. IJID Reg. 2023. PMID: 38076024 Free PMC article.
-
Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: a scoping review.Infect Dis Poverty. 2023 Jul 5;12(1):63. doi: 10.1186/s40249-023-01115-x. Infect Dis Poverty. 2023. PMID: 37403183 Free PMC article.
References
-
- INSTAT/CPS/SS-DS-PF/ICF , 2019. Enquête Démographique et de Santé au Mali 2018. Available at: https://www.dhsprogram.com/pubs/pdf/FR358/FR358.pdf. Accessed April 16, 2020.
-
- World Health Organization , 2018. World Malaria Report 2018. License: CC BY-NC-SA 3.0 IGO. Geneva, Switzerland: WHO.
-
- World Health Organization , 2012. World Malaria Report 2012. Available at: https://www.who.int/malaria/publications/world_malaria_report_2012/repor.... Accessed November 18, 2020.
-
- Medecins Sans Frontieres , 2013. Chimioprevention du Paludisme Saisnnier, district de Koutiala, Région Sikasso, Mali. Available at: https://www.msf.fr/sites/default/files/201307_cps-mali-fr.pdf. Accessed October 11, 2021.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical